Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 3
2004 8
2005 5
2006 9
2007 17
2008 18
2009 21
2010 22
2011 33
2012 21
2013 23
2014 30
2015 39
2016 36
2017 32
2018 44
2019 65
2020 74
2021 67
2022 84
2023 75
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

628 results

Results by year

Filters applied: . Clear all
Page 1
Impact of lens autofluorescence and opacification on retinal imaging.
von der Emde L, Rennen GC, Vaisband M, Hasenauer J, Liegl R, Fleckenstein M, Pfau M, Holz FG, Ach T. von der Emde L, et al. Among authors: holz fg. BMJ Open Ophthalmol. 2024 Apr 29;9(1):e001628. doi: 10.1136/bmjophth-2023-001628. BMJ Open Ophthalmol. 2024. PMID: 38684375 Free article.
Artificial Intelligence in Cataract Surgery: A Systematic Review.
Müller S, Jain M, Sachdeva B, Shah PN, Holz FG, Finger RP, Murali K, Wintergerst MWM, Schultz T. Müller S, et al. Among authors: holz fg. Transl Vis Sci Technol. 2024 Apr 2;13(4):20. doi: 10.1167/tvst.13.4.20. Transl Vis Sci Technol. 2024. PMID: 38618893 Free PMC article.
A Mild Form of RPE65-Associated Retinopathy.
Künzel SH, Rating P, Saßmannshausen M, Holz FG, Herrmann P. Künzel SH, et al. Among authors: holz fg. Klin Monbl Augenheilkd. 2024 Mar;241(3):272-274. doi: 10.1055/a-2280-1536. Epub 2024 Mar 20. Klin Monbl Augenheilkd. 2024. PMID: 38508216 Free PMC article. No abstract available.
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.
Lanzetta P, Korobelnik JF, Heier JS, Leal S, Holz FG, Clark WL, Eichenbaum D, Iida T, Xiaodong S, Berliner AJ, Schulze A, Schmelter T, Schmidt-Ott U, Zhang X, Vitti R, Chu KW, Reed K, Rao R, Bhore R, Cheng Y, Sun W, Hirshberg B, Yancopoulos GD, Wong TY; PULSAR Investigators. Lanzetta P, et al. Among authors: holz fg. Lancet. 2024 Mar 23;403(10432):1141-1152. doi: 10.1016/S0140-6736(24)00063-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461841 Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Among authors: holz fg. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
[Clinical results of the eyeWatch system: 1-year outcomes].
Weber C, Hundertmark S, Holz FG, Mercieca K. Weber C, et al. Among authors: holz fg. Ophthalmologie. 2024 Apr;121(4):298-307. doi: 10.1007/s00347-024-01994-x. Epub 2024 Feb 16. Ophthalmologie. 2024. PMID: 38363380 German.
628 results